Ian McElree
8PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 08, 2025
Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma.Ian M McElree, Vignesh T Packiam, Ryan L Steinberg
|Aug 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell
|Jul 27, 2024
Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder Tumor.Ian M McElree, Vignesh T Packiam, Ryan L Steinberg
|Jul 27, 2022
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer.Ian M McElree, Ryan L Steinberg, Alex C Martin
|Jul 13, 2022
Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder Cancer.Ian M McElree, Vignesh T Packiam, Ryan L Steinberg
Pageof 2
Frequent Collaborators
4 joint publications
Michael A O'Donnell
2 joint publications
Vignesh T Packiam
1 joint publications
Helen Y Hougen
1 joint publications
Yousef Zakharia
1 joint publications
Grant M Henning
1 joint publications
Jacob I Taylor
1 joint publications
Jeffrey Howard
1 joint publications
Mathieu Roumiguié
1 joint publications
Roger Li
1 joint publications
Yair Lotan
